您现在的位置是:【微信950216】欧博公司客服怎么联系 > 休闲
Weight regain happens 4x faster after stopping GLP
【微信950216】欧博公司客服怎么联系2026-01-31 21:54:01【休闲】7人已围观
简介Facebook TwitterThreads FlipboardCommentsPrintEmailAdd Fox News on GoogleWeigh
- Threads
- Comments
- Add Fox News on Google
Weight-loss journeys can cause social strains for GLP-1 patients, doctor says
Dr. Rocio Salas-Whalen shares how rapid GLP-1–driven weight reductions leave many individuals confronting psychological challenges that complicate relationships and social routines.
NEWYou can now listen to Fox News articles!Discontinuing the use of GLP-1 weight-loss medications triggers weight regain more than previously thought, a new study suggested.
The research, which was published in The BMJ, found that stopping the drugs is also associated with a reversal of improvements in heart and metabolic health, including cholesterol and blood pressure.
University of Oxford researchers analyzed 37 studies published up to February 2025, involving more than 9,000 participants who had undergone an average of 39 weeks of weight-loss treatment.
OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT LOSS DRUGS FOR 4 KEY REASONS
On average, patients regained about 0.9 pounds per month after stopping treatment. Researchers estimated that body weight and risk markers for diabetes and heart disease would return to pre-treatment levels in less than two years.

On average, patients regained about 0.9 pounds per month after stopping treatment. (iStock)
The analysis also revealed that the weight came back on nearly four times faster than after changing or quitting a diet or exercise regimen, no matter how many pounds had been shed.
OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU
"The evidence suggests that despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long-term weight control," the researchers commented in a press release.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The study authors acknowledged that only eight studies assessed treatment with newer GLP-1 drugs, at a maximum follow-up period of 12 months after the medication was stopped. This could serve as a limitation, although three additional methods of analysis provided similar results.

These findings question the effectiveness of GLP-1s for long-term weight loss, the researchers noted. (iStock)
In an editorial responding to the study, Dr. Qi Sun, associate professor of medicine at Brigham and Women’s Hospital and Harvard Medical School, wrote that these findings "cast doubt" on the idea that GLP-1s are a "perfect cure for obesity."
CLICK HERE FOR MORE HEALTH STORIES
"People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications," he said. "Healthy dietary and lifestyle practices should remain the foundation for obesity treatment and management, with medications such as GLP-1 receptor agonists used as adjuncts."
"Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care."
很赞哦!(822)
相关文章
- 乡镇到泰安考察学习报告
- ข่าวปลอม อย่าแชร์! ตม.ไทยคุกคาม นทท.ที่เปลี่ยนเครื่องในไทยไปกัมพูชา ไม่เป็นความจริง
- (经济观察)“十五五”时期中国如何“解锁”内需潜力?
- 时光杂货店性别怎么改 时光杂货店换性别介绍
- 悲催PC玩家!有分析称2026年可能会进入一个“没有GPU的地狱”
- 信手拈来的润肠排毒营养小菜:凉拌金针菠菜
- :创新最需要的是市场
- 中国马术协会马术星级专业教练员培训考核项目(陕西站)顺利举行
- Weight regain happens 4x faster after stopping GLP
- 令食欲大增的开胃爽口菜:肉末粉丝拌黄瓜
热门文章
站长推荐
友情链接
- Những cơ hội để thanh niên TP.Cần Thơ phát triển tương xứng với 'tầm vóc mới'
- 《死首残蜕》PC版下载 Steam正版分流下载
- iPhone18 Pro上热搜:外观感受下 多位网友吐槽丑
- Kết quả bóng đá hôm nay 22/12
- 咸鱼之王怪异咸将塔改版第一颗宝珠碎片怎么拿
- 对话视达创始人:AI创业找不对场景,就会陷入“死亡螺旋”中
- ทำไม 'เจลลี่แคท' ตุ๊กตานุ่มนิ่มหลากรูปร่างทำยอดขายทะลุพันล้านได้ในจีน
- 中铁水务内控体系建设:对标世界一流,打造治理标杆
- Những cơ hội để thanh niên TP.Cần Thơ phát triển tương xứng với 'tầm vóc mới'
- 3.1亿,合计1.2万吨/日污水厂新建计划公布
- 全国叙事性、主题性版画作品邀请展即将开展
- 不要放弃 Dont give up
- 足球宝贝自诩不爱运动 健身只为翘臀
- 做一道漂亮的孔雀开屏鱼:剁椒粉丝开屏鱼
- 中新网评:同仁堂,别再野蛮生长
- 磷虾油“零含量”,在透支同仁堂信誉
- 2017乒乓球澳洲公开赛 朱雨玲vs塩见真希女单视频
- 第50届报知电影奖揭晓:吉沢亮、北川景子分获最佳男女主角
- 2025年精选触动人心的歌词5条
- 今年宁波发生超250起并购重组事件 交易金额超370亿元






